1. A population based serologic study of hepatitis C virus infection in the United States. In: eds. Viral Hepatitis in Liver Disease, Turin: Edizioni Minerva Medic. 1997;267-270.
2. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C
3. Notices
4. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C
5. : The next epidemic. U.S. News and World Report. June 22, 1998, pp 60-66.